Navigation Links
Bernard Brigonnet Joins Baylor Research Institute as Vice President and Chief Operating Officer

DALLAS, Jan. 30 /PRNewswire-USNewswire/ -- Officials with Baylor Health Care System announced today that Bernard Brigonnet will join the Baylor Research Institute (BRI) as vice president and chief operating officer, effective Feb. 1.


Under his leadership, the institute will further pursue the development of its unique research technologies in areas such as immunology, transplantation, metabolic disease, cardiovascular disease and colon cancer, to name a few.

In addition, Brigonnet will oversee the institute's more than $40 million a year budget which has grown in just ten short years to become a major clinical research program.

"Baylor is increasingly becoming a leader in medical research and we hope to license our advanced technologies in the marketplace to reach even more patients who need them," says Michael Ramsay, M.D., president, Baylor Research Institute. "Mr. Brigonnet has a tremendous vision of where BRI can take the Baylor Health Care System and we are very excited to have someone of his caliber take us to the next level."

A native of France, Brigonnet has more than 30 years of experience in the biotechnology and pharmaceutical industries where he has served in a senior leadership capacity for a number of international organizations.

Most recently as CEO of Medicen Paris Region, he helped create one of the largest collaborations of research institutes, pharmaceutical and biotechnology companies as well as public and private universities following an initiative by the French government to support world-competitive clusters for innovation in life sciences. Prior to that, he served as president and CEO of Serono France S.A., a leader in the development and manufacturing of biopharmaceutical treatments.

As executive vice president and chief operating officer of Immuno-Designed Molecules S.A., he negotiated one of the largest partnerships with a global pharmaceutical company in Europe and subsequently opened the company's headquarters in the U.S.

He also has held executive positions with internationally-known pharmaceutical companies such as Bristol-Myers-Squibb and Merck & Co., Inc. Because of his expertise in these industries, Brigonnet has been recently called on to negotiate strategic alliances between other international corporations in the U.S. and Europe.

"BRI is currently pursuing partnerships with international companies in these industries and because of Bernard's extensive experience in this arena, he will be leading these negotiations," adds Dr. Ramsay. "Our goal is to accelerate this advanced science so that it is available to all who need it and Mr. Brigonnet will help us achieve that."

Additionally, Brigonnet will partner with the Baylor Health Care System Foundation to facilitate the development of more philanthropic support for research at Baylor.

Dallas-based Baylor Research Institute, an affiliate of Baylor Health Care System, promotes research bringing innovative treatments from the laboratory to the patient bedside. The Institute focuses on basic and translational science, clinical trials, health care effectiveness and quality of care research. Currently, investigators at Baylor are conducting 800 active research protocols spanning more than 20 medical specialties. Opened in 1996, Baylor Institute for Immunology Research, a component of BRI, focuses on developing new therapies to treat conditions that involve the immune system, such as cancer, autoimmune diseases, infectious diseases and organ transplantation.

For more information about the Baylor Research Institute visit

SOURCE Baylor Health Care System
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
2. Home Oxygen Community Applauds Senator Bernard Sanders for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
3. Bernard A. Krooks From the Special Needs Alliance to Talk Tax Strategies for Individuals With Disabilities Tomorrow on Good Morning America NOW
4. Vikings Wide Receiver Bernard Berrian Pledges Up to $10,000 to Second Harvest Heartland; Challenges the Community and Fellow Vikings to Help Feed the Hungry This Holiday Season
5. Zimmer Holdings Names Betsy Bernard to Board of Directors
6. Richard Greco Joins Mediware Board
7. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
8. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
9. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
10. Nick Childs Joins Grey New York as Director of Content Development
11. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... World Patent ... Multi Jar, a container patent that allows for easier packing and organizing of items ... is worth $90 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:12/1/2015)... ... December 02, 2015 , ... ... events and association with initiation of treatment for osteoporosis ”. , As corresponding ... pharmacological treatment in patients diagnosed with osteoporosis. Based on a large US managed ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated ... acquisition by Jordan Industries International, LLC (“JII”). , With support from JII, Integrated ... maintenance services to hospitals, surgery centers, clinics, research labs and medical facilities across ...
(Date:12/1/2015)... ... 2015 , ... According to an article published on November 16th ... the U.S. Department of Health and Human Services, claiming that any states which do ... the clause in the law prohibiting the denial of coverage for pre-existing conditions. The ...
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center ... and is the only hospital in the region providing what is known as ... transcatheter pacing patients were revealed recently at a medical conference and published in ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 As enforcement of ... Chain Security Act (DSCSA) approaches, InfiniTrak ... independent pharmacies comply with looming FDA regulations. ... is entering endorsement agreements with State Pharmacy Associations, ... administration organization (PSAO) to exclusively provide the InfiniTrak ...
(Date:12/1/2015)... ) ... "Spinal Muscular Atrophy Market - Pipeline Assessment, ... 2023" report to their offering. ... addition of the "Spinal Muscular Atrophy ... and Forecast 2015 - 2023" report ...
(Date:12/1/2015)... AMSTERDAM , Dec. 1, 2015 /PRNewswire/ -- ... announced SkyFlow , an X-ray imaging software that ... clinicians decide not to use a grid, at the ... (RSNA) 1 . SkyFlow is Philips, first digital ... for grid-less radiography, which improves clinician,s workflow and supports ...
Breaking Medicine Technology: